Early on, studies demonstrated a significant correlation between aromatase activity and tumor incidence in individual quadrants of breast tissue [25] and highlighted the need to identify factors that regulate steroid metabolism in peripheral tissue and tumors [26]. The gene discussed is CYP19A1; the disease is neoplasm.